- Home
- WLKP vs COLL Comparison
WLKP vs COLL Comparison
Compare WLKP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- COLL
- Stock Information
- Founded
- WLKP 2014
- COLL 2002
- Country
- WLKP United States
- COLL United States
- Employees
- WLKP N/A
- COLL N/A
- Industry
- WLKP Major Chemicals
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- WLKP Industrials
- COLL Health Care
- Exchange
- WLKP Nasdaq
- COLL Nasdaq
- Market Cap
- WLKP 833.7M
- COLL 934.4M
- IPO Year
- WLKP 2014
- COLL 2015
- Fundamental
- Price
- WLKP $22.15
- COLL $29.14
- Analyst Decision
- WLKP
- COLL Strong Buy
- Analyst Count
- WLKP 0
- COLL 5
- Target Price
- WLKP N/A
- COLL $43.80
- AVG Volume (30 Days)
- WLKP 33.9K
- COLL 304.8K
- Earning Date
- WLKP 05-02-2025
- COLL 05-08-2025
- Dividend Yield
- WLKP 8.52%
- COLL N/A
- EPS Growth
- WLKP N/A
- COLL N/A
- EPS
- WLKP 1.49
- COLL 1.25
- Revenue
- WLKP $1,088,852,000.00
- COLL $664,283,000.00
- Revenue This Year
- WLKP $8.90
- COLL $20.00
- Revenue Next Year
- WLKP $6.87
- COLL $3.74
- P/E Ratio
- WLKP $14.84
- COLL $23.23
- Revenue Growth
- WLKP N/A
- COLL 17.17
- 52 Week Low
- WLKP $21.19
- COLL $23.23
- 52 Week High
- WLKP $25.04
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- WLKP 37.20
- COLL 53.67
- Support Level
- WLKP $22.03
- COLL $28.78
- Resistance Level
- WLKP $22.68
- COLL $29.57
- Average True Range (ATR)
- WLKP 0.35
- COLL 0.79
- MACD
- WLKP -0.08
- COLL -0.03
- Stochastic Oscillator
- WLKP 7.69
- COLL 36.56
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.